Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 4
1991 1
1993 1
1996 1
1997 1
1998 1
2002 1
2003 1
2004 1
2007 1
2008 1
2009 2
2010 1
2014 1
2015 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
A psychoneuroendocrinology service.
Sonino N, Peruzzi P. Sonino N, et al. Psychother Psychosom. 2009;78(6):346-51. doi: 10.1159/000235738. Epub 2009 Aug 27. Psychother Psychosom. 2009. PMID: 19713729
The most frequent medical diagnoses were obesity/overweight (n = 22), hypertension (n = 20) and hypothyroidism (n = 11). The most frequent psychiatric diagnoses were major depression (n = 15), schizophrenia/schizoaffective disorder (n = 13) and …
The most frequent medical diagnoses were obesity/overweight (n = 22), hypertension (n = 20) and hypothyroidism (n = 11) …
Psychological aspects of endocrine disease.
Sonino N, Guidi J, Fava GA. Sonino N, et al. J R Coll Physicians Edinb. 2015 Mar;45(1):55-9. doi: 10.4997/JRCPE.2015.113. J R Coll Physicians Edinb. 2015. PMID: 25874833 Review.
Adrenocortical carcinoma: experience in 45 patients.
Barzon L, Fallo F, Sonino N, Daniele O, Boscaro M. Barzon L, et al. Oncology. 1997 Nov-Dec;54(6):490-6. doi: 10.1159/000227608. Oncology. 1997. PMID: 9394846
Five-year survival rate was 29% overall; for patients at stage I-II (n = 15) it was 70%, and for patients at stage III-IV (n = 30) it was 12%. In patients given mitotane + chemotherapy survival rate was similar to that observed in patients given chemotherapy alone, …
Five-year survival rate was 29% overall; for patients at stage I-II (n = 15) it was 70%, and for patients at stage III-IV (n = …
Effects of metyrapone and dexamethasone on pro-gamma-MSH and ACTH levels in depressed patients.
Sonino N, Fava GA, Morphy MA, Pedersen RC. Sonino N, et al. Eur Neuropsychopharmacol. 1990 Nov;1(1):63-5. doi: 10.1016/0924-977x(90)90013-z. Eur Neuropsychopharmacol. 1990. PMID: 1967019
There is current controversy over the mechanisms underlying hypothalamic-pituitary-adrenal (HPA) axis hyperactivity in depression. Pro-gamma-MSH, a portion of the N-terminal region of POMC, has been shown to act synergistically with ACTH in stimulating corticosteroid secre …
There is current controversy over the mechanisms underlying hypothalamic-pituitary-adrenal (HPA) axis hyperactivity in depression. Pro-gamma …
Life events in the pathogenesis of hyperprolactinemia.
Sonino N, Navarrini C, Ruini C, Fallo F, Boscaro M, Fava GA. Sonino N, et al. Eur J Endocrinol. 2004 Jul;151(1):61-5. doi: 10.1530/eje.0.1510061. Eur J Endocrinol. 2004. PMID: 15248823
The same significant difference compared with controls applied to patients with (n=16) and without (n=36) depression. All categories of events (except events that were likely to be under the subject's control) were significantly more frequent. There were no signific …
The same significant difference compared with controls applied to patients with (n=16) and without (n=36) depression. All cate …
Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls.
Morphy MA, Fava GA, Pedersen RC, Zielezny M, Sonino N, Brownie AC. Morphy MA, et al. J Affect Disord. 1990 Jul;19(3):183-9. doi: 10.1016/0165-0327(90)90090-u. J Affect Disord. 1990. PMID: 2170484
Pro-gamma-melanocyte-stimulating hormone (MSH), a portion of the N-terminal region of pro-opiomelanocortin, has been shown to act synergistically with adrenocorticotropic hormone (ACTH) in stimulating corticosteroid secretion both in vitro and in vivo. ...
Pro-gamma-melanocyte-stimulating hormone (MSH), a portion of the N-terminal region of pro-opiomelanocortin, has been shown to act syn …
Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.
Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D. Sonino N, et al. Clin Endocrinol (Oxf). 1991 Oct;35(4):347-52. doi: 10.1111/j.1365-2265.1991.tb03547.x. Clin Endocrinol (Oxf). 1991. PMID: 1752063
RESULTS: Comparing the last values (mean +/- SEM) during treatment with baseline, urinary cortisol decreased from 1296 +/- 176 to 270 +/- 69 nmol/d (n = 34; P less than 0.001); plasma cortisol decreased from 672 +/- 31 to 549 +/- 35 nmol/l (n = 34; P less than 0.001 …
RESULTS: Comparing the last values (mean +/- SEM) during treatment with baseline, urinary cortisol decreased from 1296 +/- 176 to 270 +/- 69 …
20 results